福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRTX 福泰制药

盘前交易 11-20 05:34:10 EST

448.01

-19.00

-4.07%

盘前448.00

-0.01+0.00%

05:30 EST

最高463.90	最低447.14	成交量219.25万
今开462.80	昨收467.01	日振幅3.59%
总市值1,154亿	流通市值1,150亿	总股本2.58亿
成交额9.93亿	换手率0.85%	流通股本2.57亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRTX","market":"US","secType":"STK","nameCN":"福泰制药","latestPrice":448.01,"timestamp":1732050000000,"preClose":467.01,"halted":0,"volume":2192527,"hourTrading":{"tag":"盘前","latestPrice":448,"preClose":448.01,"latestTime":"05:30 EST","volume":18,"amount":8064.009899999999,"timestamp":1732098603087},"delay":0,"floatShares":256789562,"shares":257529290,"eps":-1.862279,"marketStatus":"盘前交易","marketStatusCode":1,"change":-19,"latestTime":"11-20 05:34:10 EST","open":462.8,"high":463.9,"low":447.14,"amount":993054895.7817,"amplitude":0.035888,"askPrice":450.44,"askSize":2,"bidPrice":447.29,"bidSize":2,"shortable":3,"etf":0,"ttmEps":-1.862279,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732113000000},"adr":0,"adjPreClose":448.01,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":448,"preClose":448.01,"latestTime":"05:30 EST","volume":18,"amount":8064.009899999999,"timestamp":1732098603087},"postHourTrading":{"tag":"盘后","latestPrice":448.01,"preClose":448.01,"latestTime":"19:56 EST","volume":65637,"amount":29406089.122,"timestamp":1732064187004},"volumeRatio":1.484190178875917,"impliedVol":0.4324,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/VRTX","defaultTab":"news","newsList":[{"id":"1118850472","title":"花旗推荐吉利德和Vertex为生物科技新兴大买入标的","url":"https://stock-news.laohu8.com/highlight/detail?id=1118850472","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118850472?lang=zh_cn&edition=full","pubTime":"2024-11-15 10:12","pubTimestamp":1731636736,"startTime":"0","endTime":"0","summary":"$花旗$银行将$吉利德科学$公司和Vertex制药公司列为“买入”评级，认为前者将受益于抗病毒药物Biktarvy的短期增长和新药Sunlenca的长期增长。Vertex预计将继续保持在囊性纤维化治疗市场的领导地位，并在急性疼痛领域拓展其新药Suzetrigine，预计FDA将在2025年1月30日决定其审批结果。花旗为吉利德设定的目标价为125美元，而Vertex的目标价为575美元。对于Vertex，花旗预计其囊性纤维化药物Vanza三联疗法将在2030年实现80亿美元的风险调整后峰值销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0079474960.USD","VRTX","IE00B19Z3581.USD","BK4207","159837","LU1162221912.USD","LU2360032135.SGD","BK4588","LU0109394709.USD","LU0417517546.SGD","IE00B19Z3B42.SGD","LU2125154778.USD","C","LU0128525689.USD","IE00BSNM7G36.USD","LU1267930227.SGD","LU0130517989.USD","LU0320765992.SGD","VERX","LU1366192091.USD"],"gpt_icon":0},{"id":"2482087809","title":"福泰制药跌0.49% 股价跌破500美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2482087809","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482087809?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:47","pubTimestamp":1731426458,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时47分，福泰制药股票出现异动，股价快速下挫0.49%。截至发稿，该股报499.27美元/股，成交量13.8437万股，换手率0.05%，振幅1.64%。福泰制药股票所在的生物技术行业中，整体跌幅为0.44%。福泰制药公司简介：Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外，Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112234738a230e34f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112234738a230e34f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","BK4567","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00BJT1NW94.SGD","LU0234570918.USD","BK4533","BK4532","IE00BZ9MQY76.HKD","LU0256863811.USD","IE00B2B36J28.USD","LU0061475181.USD","LU2417539215.USD","LU1069344957.HKD","LU0320765992.SGD","LU0289739699.SGD","LU0058720904.USD","LU0417517546.SGD","BK4585","BK4588","IE00B19Z3581.USD","LU2362541273.HKD","LU1585245621.USD","LU2236285917.USD","IE00B19Z3B42.SGD","VRTX","LU0079474960.USD","LU2462157665.USD","LU1093756168.USD","BK4139","LU0109394709.USD","LU2456880835.USD","LU2362540622.SGD","IE00B19Z9P08.USD","LU1035775433.USD","LU1430594728.SGD","LU2324357040.USD","IE0002270589.USD","LU2362541513.USD","IE0002141913.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BFTCPJ56.SGD","IE0009355771.USD","LU0823416689.USD","IE00B19Z9Z06.USD","LU2237438978.USD"],"gpt_icon":0},{"id":"2482732605","title":"Vertex, Inc.2024财年第三财季实现净利润7.22百万美元，同比增加312.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482732605","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482732605?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:00","pubTimestamp":1731340825,"startTime":"0","endTime":"0","summary":"11月12日，Vertex, Inc.公布财报，公告显示公司2024财年第三财季净利润为7.22百万美元，同比增加312.35%；其中营业收入为1.70亿美元，同比增加17.24%，每股基本收益为0.05美元。从资产负债表来看，Vertex, Inc.总负债9.32亿美元，其中短期债务3.95百万美元，资产负债比为1.28，流动比率为1.04。机构评级：截至2024年11月12日，当前有11家机构对Vertex, Inc.目标价做出预测，其中目标均价为55.18美元，其中最低目标价为46.00美元，最高目标价为61.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000033abb68b93&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000033abb68b93&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VERX","VRTX"],"gpt_icon":0},{"id":"2482733381","title":"Vertex, Inc.盘中异动 早盘急速下挫5.17%报49.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482733381","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482733381?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:35","pubTimestamp":1731335700,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时35分，Vertex, Inc.股票出现波动，股价大幅下挫5.17%。截至发稿，该股报49.30美元/股，成交量11.8015万股，换手率0.08%，振幅1.88%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.60%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223500971a5b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223500971a5b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B894F039.SGD","LU0109394709.USD","LU1035775433.USD","LU0234570918.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2462157665.USD","IE00BZ9MQY76.HKD","IE0002270589.USD","BK4532","BK4533","LU0256863811.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","LU0823416689.USD","VRTX","IE0002141913.USD","LU1069344957.HKD","IE00B2B36J28.USD","BK4567","IE0009355771.USD","BK4023","LU0417517546.SGD","LU0079474960.USD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU2324357040.USD","VERX","IE00B19Z3581.USD","LU2237438978.USD","LU0889565916.HKD","LU2456880835.USD","LU1093756168.USD","BK4588","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0061475181.USD","BK4585","LU0289739699.SGD","LU2362541273.HKD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2236285917.USD","LU1093756325.SGD","BK4139","LU2362540622.SGD"],"gpt_icon":0},{"id":"2482422208","title":"福泰制药2024财年第三财季实现净利润10.45亿美元，同比增加0.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482422208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482422208?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168204,"startTime":"0","endTime":"0","summary":"11月10日，福泰制药公布财报，公告显示公司2024财年第三财季净利润为10.45亿美元，同比增加0.97%；其中营业收入为27.75亿美元，同比增加11.85%，每股基本收益为4.05美元。机构评级：截至2024年11月10日，当前有28家机构对福泰制药目标价做出预测，其中目标均价为521.04美元，其中最低目标价为325.00美元，最高目标价为602.00美元。此外，Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000415abb1018e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000415abb1018e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRTX"],"gpt_icon":0},{"id":"2481396261","title":"福泰制药涨1.29% 股价突破500美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2481396261","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481396261?lang=zh_cn&edition=full","pubTime":"2024-11-08 01:24","pubTimestamp":1731000241,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日01时24分，福泰制药股票出现异动，股价急速拉升1.29%。截至发稿，该股报500.01美元/股，成交量25.5988万股，换手率0.10%，振幅2.42%。福泰制药股票所在的生物技术行业中，整体涨幅为0.92%。福泰制药公司简介：Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。此外，Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110801240198e41423&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110801240198e41423&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1093756168.USD","LU1069344957.HKD","LU0234570918.USD","IE00BZ9MQY76.HKD","LU0417517546.SGD","LU2362541273.HKD","BK4567","BK4585","LU2417539215.USD","LU0289739699.SGD","LU1093756325.SGD","LU0320765992.SGD","IE0009355771.USD","LU1585245621.USD","IE0002270589.USD","LU1035775433.USD","LU0061475181.USD","IE00B2B36J28.USD","IE00B19Z9Z06.USD","BK4532","LU2462157665.USD","LU0889565916.HKD","IE00B4R5TH58.HKD","LU2362541513.USD","IE0002141913.USD","LU0256863811.USD","LU0109394709.USD","LU2362540622.SGD","IE00BFTCPJ56.SGD","BK4139","BK4588","IE00B19Z3581.USD","IE00B19Z3B42.SGD","BK4533","LU0079474960.USD","IE00B894F039.SGD","LU1430594728.SGD","LU0823416689.USD","VRTX","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2324357040.USD","LU2456880835.USD","IE00B19Z9P08.USD","LU2236285917.USD","LU2237438978.USD"],"gpt_icon":0},{"id":"2481988887","title":"Vertex, Inc.盘中异动 股价大涨5.06%报45.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481988887","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481988887?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:31","pubTimestamp":1730903507,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时31分，Vertex, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报45.92美元/股，成交量2.8937万股，换手率0.02%，振幅1.19%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为1.09%。其相关个股中，Datchat, Inc.、Rumble Inc C/Wts 16/09/2027 、Phunware, Inc.涨幅较大，Datchat, Inc.、Phunware, Inc.、Earlyworks Co Ltd较为活跃，换手率分别为1140.86%、63.89%、35.11%，振幅较大的相关个股有Mogo Inc.、Rackspace Technology, Inc.、Soundthinking, Inc.，振幅分别为106.75%、106.25%、105.26%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223147971a4bbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106223147971a4bbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1069344957.HKD","IE0002141913.USD","BK4567","IE00B4R5TH58.HKD","VRTX","IE00B19Z3B42.SGD","LU2362541273.HKD","LU0417517546.SGD","IE00BFTCPJ56.SGD","LU0061475181.USD","BK4588","BK4585","IE00B19Z9Z06.USD","LU0889565916.HKD","IE0009355771.USD","LU0823416689.USD","LU1430594728.SGD","LU2324357040.USD","VERX","LU2417539215.USD","IE00B2B36J28.USD","LU0109394709.USD","LU2456880835.USD","BK4533","IE00BJT1NW94.SGD","LU0079474960.USD","LU0234570918.USD","IE00BZ9MQY76.HKD","LU2462157665.USD","IE00B894F039.SGD","LU2236285917.USD","LU2362541513.USD","LU0320765992.SGD","LU1093756325.SGD","BK4023","IE0002270589.USD","LU2237438978.USD","LU0058720904.USD","LU1035775433.USD","BK4139","IE00B19Z3581.USD","BK4532","LU0289739699.SGD","LU1093756168.USD","IE00B19Z9P08.USD","LU0256863811.USD","IE00BJJMRZ35.SGD","LU2362540622.SGD","LU1585245621.USD"],"gpt_icon":0},{"id":"1191487750","title":"异动解读 | 福泰制药第三季度业绩超预期并上调全年收入预期,股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1191487750","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191487750?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:16","pubTimestamp":1730826999,"startTime":"0","endTime":"0","summary":"2024年11月5日,生物技术公司福泰制药的股价出现大涨,盘中最高上涨5.04%,引发市场广泛关注。从公开信息来看,该公司近期发布的第三季度财报好于市场预期,成为推动股价上涨的主要动力。受业绩增长影响,公司上调了2024全年营收预期,从此前的106.5亿美元到108.5亿美元,上调至108亿美元至109亿美元区间。此外,福泰制药也在监管批准和新产品研发方面取得进展,这进一步提振了对其未来增长前景的预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 福泰制药第三季度业绩超预期并上调全年收入预期,股价大涨5.04%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["VRTX"],"gpt_icon":0},{"id":"2481638456","title":"福泰制药盘中异动 急速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481638456","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481638456?lang=zh_cn&edition=full","pubTime":"2024-11-06 01:14","pubTimestamp":1730826877,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日01时14分，福泰制药股票出现波动，股价大幅上涨5.04%。福泰制药股票所在的生物技术行业中，整体涨幅为1.38%。福泰制药公司简介：Vertex Pharmaceuticals 是一家发现和开发用于治疗严重疾病的小分子药物的全球生物技术公司。其主要药物是Kalydeco、Orkambi、Symdeko 和 用于治疗囊性纤维化的Trikafta/Kaftrio，其中 Vertex 疗法仍然是全球治疗标准。此外，Vertex 正在评估使用非阿片类药物治疗的针对急性和慢性疼痛的小分子抑制剂，以及 APOL1 介导的肾脏疾病的小分子抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601143798e409a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110601143798e409a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2236285917.USD","LU0289739699.SGD","LU0079474960.USD","LU2362541273.HKD","LU1430594728.SGD","IE00BZ9MQY76.HKD","LU0889565916.HKD","LU0234570918.USD","IE00BJJMRZ35.SGD","LU0058720904.USD","LU0823416689.USD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU2462157665.USD","IE0002141913.USD","LU2362541513.USD","BK4588","BK4533","LU0109394709.USD","IE00B19Z3581.USD","LU1093756325.SGD","LU1585245621.USD","LU0256863811.USD","LU2362540622.SGD","IE00B2B36J28.USD","VRTX","LU1093756168.USD","LU0320765992.SGD","LU2237438978.USD","LU1035775433.USD","LU1069344957.HKD","BK4567","IE0009355771.USD","IE00B19Z9P08.USD","IE00B4R5TH58.HKD","LU2456880835.USD","LU2324357040.USD","LU0417517546.SGD","LU2417539215.USD","IE00BFTCPJ56.SGD","BK4532","BK4585","IE00B894F039.SGD","IE0002270589.USD","BK4139","LU0061475181.USD","IE00B19Z9Z06.USD"],"gpt_icon":0},{"id":"2481879456","title":"BUZZ-Vertex Pharma上调2024年收入预期后股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2481879456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481879456?lang=zh_cn&edition=full","pubTime":"2024-11-06 00:39","pubTimestamp":1730824752,"startTime":"0","endTime":"0","summary":"    11月5日 - ** Vertex Pharmaceuticals   股价在早盘交易中上涨4.3%，至493.07美元** 如果涨势保持，该股将创下自2023年12月以来的最佳表现** 周一晚些时候，制药公司上调了 ，从之前预期的106.5亿美元到108.5亿美元，上调至108亿美元到109亿美元之间。** 根据 LSEG 编制的数据，该公司第三季度的营业收入为 27.7 亿美元，高于华尔街预期的 27.2 亿美元。** VRTX 第三季度每股收益为 4.38 美元，高于预期的 4.14 美元。** 今年以来，股价上涨了 20.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0058720904.USD","LU0109394709.USD","LU2456880835.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE0002141913.USD","LU2362541513.USD","IE00B19Z3B42.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","BK4023","BK4532","IE00BFTCPJ56.SGD","LU0256863811.USD","VRTX","LU1585245621.USD","LU2462157665.USD","IE00B2B36J28.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU1035775433.USD","BK4567","BK4533","VERX","BK4139","LU2362540622.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","LU2236285917.USD","IE0009355771.USD","BK4588","IE00BJT1NW94.SGD","IE00B19Z3581.USD","IE0002270589.USD","LU0061475181.USD","LU2324357040.USD","LU2417539215.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU1430594728.SGD","LU0234570918.USD","LU0417517546.SGD","LU1069344957.HKD","LU2237438978.USD","LU0320765992.SGD","BK4585","LU0079474960.USD"],"gpt_icon":0},{"id":"2481899596","title":"BUZZ-早期试验中患者死亡，Beam Therapeutics 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2481899596","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481899596?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:40","pubTimestamp":1730821201,"startTime":"0","endTime":"0","summary":"    11月5日 - ** 生物技术公司Beam Therapeutics   股价下跌3.30%，至23.56美元** 摘要显示，在该公司基于CRISPR技术的细胞疗法BEAM-101的早中期试验中，一名镰状细胞病患者因呼吸衰竭死亡。** Vertex  和CRISPR Therapeutics的  Casgevy和蓝鸟生物的  Lyfgenia被批准用于治疗镰状细胞病，这是一组遗传性血液疾病。** BEAM 第三季度净亏损为 9,670 万美元，合每股亏损 1.17 美元，去年同期净亏损为 9,610 万美元，合每股亏损 1.22 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00B19Z3581.USD","LU2362541513.USD","LU1093756325.SGD","BLUE","BK4139","LU1430594728.SGD","IE00BJJMRZ35.SGD","LU0417517546.SGD","VRTX","IE0009355771.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1093756168.USD","BK4585","IE00B19Z9P08.USD","BK4567","IE00BZ9MQY76.HKD","LU2362540622.SGD","LU0889565916.HKD","LU1585245621.USD","IE0002270589.USD","LU2236285917.USD","BK4532","BEAM","LU0256863811.USD","IE0002141913.USD","IE00B19Z9Z06.USD","IE00BFTCPJ56.SGD","BK4535","LU2237438978.USD","LU2456880835.USD","LU0079474960.USD","IE00B4R5TH58.HKD","BK4533","LU2324357040.USD","LU0289739699.SGD","BK4578","IE00B894F039.SGD","BK4556","LU0061475181.USD","LU1069344957.HKD","LENZ","LU0823416689.USD","LU2462157665.USD","LU0234570918.USD","LU2417539215.USD","LU0058720904.USD","IE00B19Z3B42.SGD","BK4505"],"gpt_icon":0},{"id":"2481554349","title":"Vertex Pharma 凭借囊性纤维化治疗的优势上调年度收入预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2481554349","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481554349?lang=zh_cn&edition=full","pubTime":"2024-11-05 05:01","pubTimestamp":1730754094,"startTime":"0","endTime":"0","summary":"    路透11月4日 - Vertex Pharmaceuticals   因囊性纤维化 治疗需求旺盛，第三季度业绩超出预期，该公司周一上调了全年营收预期。本周一，该公司的第三季度收入也超过了预期，这主要得益于对其CF治疗药物的强劲需求。美国卫生监管机构预计将在 1 月份对 Vertex 公司申请将这种非阿片类药物作为中度至重度急性疼痛治疗药物的申请做出决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LU1093756168.USD","BK4585","LU2362541273.HKD","BK4567","LU0320765992.SGD","LU1585245621.USD","LU2237438978.USD","LU0417517546.SGD","LU1093756325.SGD","LU2362540622.SGD","LU1430594728.SGD","IE00BJT1NW94.SGD","IE00B19Z3B42.SGD","LU0823416689.USD","LU2362541513.USD","LU2462157665.USD","VRTX","LU0061475181.USD","IE00BJJMRZ35.SGD","IE00B894F039.SGD","IE00B2B36J28.USD","LU1035775433.USD","LU0109394709.USD","IE00B4R5TH58.HKD","LU0079474960.USD","IE00B19Z3581.USD","IE0009355771.USD","BK4533","LU0058720904.USD","LU0289739699.SGD","IE00B19Z9P08.USD","IE00BFTCPJ56.SGD","LU0256863811.USD","LU2324357040.USD","IE00B19Z9Z06.USD","IE00BZ9MQY76.HKD","LU2236285917.USD","LU2417539215.USD","IE0002270589.USD","LU2456880835.USD","VERX","BK4532","BK4023","LU1069344957.HKD","LU0889565916.HKD","BK4588","LU0234570918.USD","IE0002141913.USD"],"gpt_icon":0},{"id":"2480580094","title":"Vertex Inc    预计每股收益 14 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2480580094","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480580094?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:49","pubTimestamp":1730735363,"startTime":"0","endTime":"0","summary":"   * Vertex公司   将于11月6日公布截至2024年9月30日的业绩报告，预计该公司的季度收入将有所增长。* LSEG 分析师对 Vertex Inc 的平均预期为每股收益 14 美分。* 华尔街对 Vertex Inc 的 12 个月目标价中位数为 42.00 美元，低于其上次收盘价 42.17 美元。11月4日 - 该公司2024年8月7日发布的截至9月30日的业绩指导是：未计利息、税项、折旧及摊销前的利润为1.64亿美元至3500万美元。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRTX","VERX"],"gpt_icon":0},{"id":"2479124485","title":"美国研究综述-Alphabet、Arthur J. Gallagher & Co、Leggett & Platt","url":"https://stock-news.laohu8.com/highlight/detail?id=2479124485","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479124485?lang=zh_cn&edition=full","pubTime":"2024-10-30 14:34","pubTimestamp":1730270081,"startTime":"0","endTime":"0","summary":"    路透10月30日 - 华尔街证券分析师周三调整了对Alphabet、Arthur J. Gallagher & Co和Leggett & Platt等多家美国上市公司的评级和目标价。* Arthur J. Gallagher & Co：TD Cowen 将目标价从 288 美元上调至 295 美元 * Leggett & Platt Inc   ：Piper Sandler 将其评级从 \"减持 \"上调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"86620ca5f985192b0de68ba1fc9648ed","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0528227936.USD","WM","CMG","IE00BN0W2V16.EUR","WERN","ZBRA","LU0127658192.USD","ESAB","BMRN","CZR","SYY","TXG","IE00BN0W2W23.USD","LU2362541273.HKD","VRTX","XRX","LU2362541513.USD","GLW","LU0265550359.USD","SYK","PRO","AJG","LU2468319806.SGD","SGXZ31699556.SGD","LU1093756168.USD","GOOG","MDLZ","GOOGL","DHI","BK4567","LSTR","SAFE","LEG","RSG","EA","IE0004086264.USD","IE00BN0W2T93.GBP","UBER","LU1366333091.USD","LU","TWO","BK4161","LU2089279066.USD","QRVO","IE00BFSS8Q28.SGD","LU2272731865.HKD"],"gpt_icon":1},{"id":"2479343183","title":"花旗：将把多个工作负载和应用程序迁移至谷歌云。将使用谷歌云的Vertex AI以增强生成式人工智能能力。","url":"https://stock-news.laohu8.com/highlight/detail?id=2479343183","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479343183?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:33","pubTimestamp":1730133187,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU0082616367.USD","IE00B19Z9P08.USD","LU0128525929.USD","LU0234572021.USD","LU2456880835.USD","VERX","LU0072461881.USD","IE00B4JS1V06.HKD","LU1201861249.SGD","LU1162221912.USD","LU0456855351.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU0068578508.USD","IE0009356076.USD","IE00B4R5TH58.HKD","LU0130103400.USD","LU1267930227.SGD","BK4503","LU0158827948.USD","LU0198837287.USD","LU0048584097.USD","LU0823416689.USD","BK4139","BK4574","IE00B1BXHZ80.USD","LU0128525689.USD","IE00BFSS8Q28.SGD","LU0320765646.SGD","LU0127658192.USD","BK4588","161631","IE00B5949003.HKD","BK4514","LU0029864427.USD","LU0061474705.USD","LU2324357040.USD","GOOG","LU0187121727.USD","LU0211327993.USD","LU0225283273.USD","VRTX","LU0079474960.USD","GOOGL","LU0175139822.USD","BK4587","IE00B1XK9C88.USD","LU2236285917.USD","IE0005OL40V9.USD"],"gpt_icon":0},{"id":"2472776335","title":"Vertex, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472776335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472776335?lang=zh_cn&edition=full","pubTime":"2024-10-03 02:04","pubTimestamp":1727892285,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日02时04分，Vertex, Inc.股票出现异动，股价急速拉升5.05%。截至发稿，该股报41.19美元/股，成交量59.2452万股，换手率0.38%，振幅6.30%。Vertex, Inc.股票所在的软件服务行业中，整体涨幅为0.22%。Vertex, Inc.公司简介：Vertex Inc是一家提供税务技术和服务的公司。Vertex为特定行业提供基于云和内部部署的解决方案，涵盖收入、销售、消费者使用、增值和工资等各个税种。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003020446a1de090b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003020446a1de090b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B894F039.SGD","LU0109394709.USD","LU1035775433.USD","LU0234570918.USD","LU2362541513.USD","IE00B4R5TH58.HKD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2462157665.USD","IE00BZ9MQY76.HKD","IE0002270589.USD","BK4532","BK4533","LU0256863811.USD","IE00BJJMRZ35.SGD","LU2417539215.USD","LU0823416689.USD","VRTX","IE0002141913.USD","LU1069344957.HKD","IE00B2B36J28.USD","BK4567","IE0009355771.USD","BK4023","LU0417517546.SGD","LU0079474960.USD","IE00BJT1NW94.SGD","IE00B19Z9P08.USD","LU2324357040.USD","VERX","IE00B19Z3581.USD","LU2237438978.USD","LU0889565916.HKD","LU2456880835.USD","LU1093756168.USD","BK4588","IE00B19Z9Z06.USD","LU0320765992.SGD","LU0061475181.USD","BK4585","LU0289739699.SGD","LU2362541273.HKD","LU1585245621.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","LU2236285917.USD","LU1093756325.SGD","BK4139","LU2362540622.SGD"],"gpt_icon":0},{"id":"2470075677","title":"分析师称，辉瑞退出 Oxbryta 可能会加速竞争对手试验性镰状细胞药物的试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2470075677","media":"Reuters","labels":["Policy And Regulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470075677?lang=zh_cn&edition=full","pubTime":"2024-09-26 23:36","pubTimestamp":1727364983,"startTime":"0","endTime":"0","summary":"Oxbryta是至少六种镰状细胞病治疗药物之一，主要用于轻度至中度症状的患者。至少有三家华尔街券商表示，撤销授权可能会导致立即加快对竞争对手的治疗遗传性疾病的药物进行试验，包括Agios Pharmaceuticals公司的   mitapivat和Fulcrum Therapeutics公司的   pociredir。Stifel 公司分析师 Dae Gon Ha 周四表示，Oxbryta 的停产可能会使绝大多数轻中度患者依赖化疗药物羟基脲。据辉瑞公司网站介绍，该公司还收购了另外两种试验性镰状细胞疗法，这两种疗法目前仍在临床试验中。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"31475a2f05bb5a0cf2e7acfeae2c0e13","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Policy And Regulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","SGXZ57979304.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU2362540622.SGD","SG9999001176.USD","SG9999013999.USD","IE00BLSP4452.SGD","LU0225771236.USD","LU0234570918.USD","LU2236285917.USD","LU1585245621.USD","IE00BBT3K403.USD","LU0321505868.SGD","LU2417539215.USD","LU0321505439.SGD","IE00BJT1NW94.SGD","LU0417517546.SGD","PIPR","BK4533","LU1035775433.USD","IE00BLSP4239.USD","BK4007","FULC","LU0256863811.USD","LU0122379950.USD","BK4127","SG9999001176.SGD","LU0058720904.USD","LU1023059063.AUD","BK4532","LU0061475181.USD","LU0234572021.USD","LU0868494617.USD","BK4550","LU0289739699.SGD","LU1093756168.USD","IE00B894F039.SGD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU2237438978.USD","LU1894683348.USD","IE00B19Z9P08.USD","BK4567","BK4534","LU1066051498.USD","VRTX","IE000M9KFDE8.USD","LU1057294990.SGD","IE00B19Z9Z06.USD"],"gpt_icon":1},{"id":"2470234304","title":"BUZZ-Vertex Energy 申请破产保护后股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2470234304","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470234304?lang=zh_cn&edition=full","pubTime":"2024-09-25 18:19","pubTimestamp":1727259550,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月25日 - ** 美国能源公司顶点能源  股价盘前下跌~56%至16美分** 该公司周二向德克萨斯州一家法院申请破产保护 (link) ** 表示将探索出售事宜，作为与贷方达成的重组协议的一部分** VTNR 还将获得 8000 万美元的债务人持有融资 (link)，以充分支持日常运营** 截至最后收盘，股价累计下跌 89.35","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541273.HKD","LU0058720904.USD","LU0109394709.USD","LU2456880835.USD","LU0289739699.SGD","IE00BZ9MQY76.HKD","IE0002141913.USD","LU2362541513.USD","IE00B19Z3B42.SGD","LU1093756168.USD","IE00BJJMRZ35.SGD","BK4023","BK4532","IE00BFTCPJ56.SGD","LU0256863811.USD","VRTX","LU1585245621.USD","LU2462157665.USD","IE00B2B36J28.USD","LU0823416689.USD","IE00B19Z9P08.USD","LU1035775433.USD","BK4567","BK4533","VERX","VTNR","BK4139","LU2362540622.SGD","LU0889565916.HKD","IE00B19Z9Z06.USD","LU2236285917.USD","BK4588","IE00BJT1NW94.SGD","IE00B19Z3581.USD","IE0002270589.USD","BK4138","LU0061475181.USD","LU2324357040.USD","LU2417539215.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00B4R5TH58.HKD","LU1430594728.SGD","LU0234570918.USD","LU0417517546.SGD","LU1069344957.HKD","LU2237438978.USD","LU0320765992.SGD","BK4585","LU0079474960.USD"],"gpt_icon":0},{"id":"2469049206","title":"更新版 2-蓝鸟生物将裁员 25%，以应对资金紧张问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2469049206","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469049206?lang=zh_cn&edition=full","pubTime":"2024-09-24 19:29","pubTimestamp":1727177354,"startTime":"0","endTime":"0","summary":"更新版 2-蓝鸟生物将裁员 25%，以应对资金紧张问题第5段增加了首席执行官声明，全文增加了背景信息。路透9月24日 - 基因疗法生产商蓝鸟生物BLUE.O周二表示，将裁员约25%，即95名员工，这是公司两年来的第二次重大重组，因为公司在资金紧张的情况下专注于推出其疗法。该公司表示，到2025年第三季度，最新的重组将使其现金运营支出减少20%。蓝鸟生物在过去两年中一直引发持续经营的质疑，该公司已裁员30%， ，以便在2022年节省1.6亿美元的成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240924:nL4T3L611F:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU0320765992.SGD","IE00B19Z3B42.SGD","LU1430594728.SGD","LU1093756168.USD","LU2362541273.HKD","IE00BJJMRZ35.SGD","LU0058720904.USD","VRTX","LU1093756325.SGD","BK4533","LU2236285917.USD","BK4585","LU0109394709.USD","BLUE","IE00B4R5TH58.HKD","LU0889565916.HKD","IE00B894F039.SGD","IE00BZ9MQY76.HKD","BK4567","LU1069344957.HKD","BK4578","LU2456880835.USD","IE00B19Z9Z06.USD","LU2362540622.SGD","IE00BJT1NW94.SGD","LU0823416689.USD","LU0256863811.USD","LU0289739699.SGD","IE00B19Z9P08.USD","IE0009355771.USD","LU0417517546.SGD","IE00B2B36J28.USD","LU2362541513.USD","BK4139","LU1585245621.USD","LU0234570918.USD","BK4556","IE00B19Z3581.USD","LU2237438978.USD","LU2417539215.USD","LU0061475181.USD","LU2324357040.USD","IE0002141913.USD","LU1035775433.USD","BK4532","IE0002270589.USD","LU0079474960.USD","LU2462157665.USD","BK4588"],"gpt_icon":0},{"id":"2468593967","title":"福泰制药(VRTX)：高级副总裁提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2468593967","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468593967?lang=zh_cn&edition=full","pubTime":"2024-09-19 08:57","pubTimestamp":1726707420,"startTime":"0","endTime":"0","summary":"福泰制药在2024年的Jefferies工业会议上，高级副总裁Susie Lisa讨论了公司的当前状况和未来方向。她强调了公司在囊性纤维化治疗领域的强劲商业执行力，并提高了指导预期至106.5亿至108.5亿美元，反映出9%的增长。Lisa还提到了公司在疼痛治疗领域的多元化商业战略，特别是在慢性疼痛和外周神经性疼痛方面的进展，以及公司在糖尿病细胞疗法方面的研究。Lisa对公司的长期增长潜力持乐观态度，并强调了公司在生产力提升和资源分配方面的战略重点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/2024-09-19/doc-incprwmu7159855.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/2024-09-19/doc-incprwmu7159855.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00B19Z9Z06.USD","BK4588","IE00B19Z3581.USD","BK4585","LU1093756168.USD","LU0234570918.USD","IE00BJJMRZ35.SGD","IE0002270589.USD","LU0889565916.HKD","LU2456880835.USD","BK4532","VRTX","BK4139","LU2417539215.USD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0079474960.USD","IE00B2B36J28.USD","LU0417517546.SGD","LU2362540622.SGD","LU2324357040.USD","IE00BZ9MQY76.HKD","LU2237438978.USD","LU0058720904.USD","LU2362541273.HKD","LU0256863811.USD","IE0009355771.USD","IE00B894F039.SGD","LU2362541513.USD","LU0061475181.USD","LU0823416689.USD","LU1430594728.SGD","IE00BFTCPJ56.SGD","LU2236285917.USD","LU1035775433.USD","LU1093756325.SGD","LU0320765992.SGD","LU2462157665.USD","IE0002141913.USD","LU1069344957.HKD","BK4567","LU0109394709.USD","IE00B19Z9P08.USD","LU1585245621.USD","BK4533","IE00B19Z3B42.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vrtx.com","stockEarnings":[{"period":"1week","weight":-0.0857},{"period":"1month","weight":-0.0724},{"period":"3month","weight":-0.0784},{"period":"6month","weight":-0.0062},{"period":"1year","weight":0.2555},{"period":"ytd","weight":0.1011}],"compareEarnings":[{"period":"1week","weight":-0.0111},{"period":"1month","weight":0.0098},{"period":"3month","weight":0.0529},{"period":"6month","weight":0.1223},{"period":"1year","weight":0.2995},{"period":"ytd","weight":0.2419}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vertex Pharmaceuticals Incorporated成立于1989年,是一家全球性生物技术公司。公司致力于发现、开发、生产和商业化用于专业市场严重疾病的小分子药物。公司与一些世界上最大的制药公司、领先的非盈利性疾病研究机构及许多世界上最知名的学术机构都有合作关系。公司有两款产品：KALYDECO和INCIVEK。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.030934},{"month":2,"riseRate":0.424242,"avgChangeRate":-0.001228},{"month":3,"riseRate":0.424242,"avgChangeRate":-0.020541},{"month":4,"riseRate":0.606061,"avgChangeRate":0.017109},{"month":5,"riseRate":0.575758,"avgChangeRate":0.084187},{"month":6,"riseRate":0.545455,"avgChangeRate":0.029065},{"month":7,"riseRate":0.454545,"avgChangeRate":-0.005556},{"month":8,"riseRate":0.647059,"avgChangeRate":0.051926},{"month":9,"riseRate":0.470588,"avgChangeRate":0.031033},{"month":10,"riseRate":0.529412,"avgChangeRate":-0.001666},{"month":11,"riseRate":0.470588,"avgChangeRate":-0.022655},{"month":12,"riseRate":0.666667,"avgChangeRate":0.078782}],"exchange":"NASDAQ","name":"福泰制药","nameEN":"Vertex Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"福泰制药,VRTX,福泰制药股票,福泰制药股票老虎,福泰制药股票老虎国际,福泰制药行情,福泰制药股票行情,福泰制药股价,福泰制药股市,福泰制药股票价格,福泰制药股票交易,福泰制药股票购买,福泰制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"福泰制药(VRTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供福泰制药(VRTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}